Dual Effect of Nitric Oxide in Articular Inflammatory Pain in Zymosan-induced Arthritis in Rats

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2002 Jun 11

PMID 12055137

Citations 15

Authors

Jose C da S Rocha

Magno E B Peixoto

Sonia Jancar

Fernando de Q Cunha

Ronaldo de A Ribeiro

Francisco A C da Rocha

Affiliations

Soon will be listed here.

Abstract

The contribution of nitric oxide (NO) to articular pain in arthritis induced by zymosan (1 mg, intra articular) in rats was assessed by measuring articular incapacitation (AI). Systemic treatment with the non-selective NO synthase (NOS) inhibitor L-NAME (10 - 100 mg kg(-1) i.p.) or with the selective iNOS inhibitors aminoguanidine (AG; 10 - 100 mg kg(-1) i.p.) or 1400W (0.5 - 1 mg kg(-1) s.c.) inhibited the AI induced by injection of zymosan 30 min later. Local (intra articular) treatment with the NOS inhibitors (L-NAME or AG, 0.1 - 1 micromol; 1400W, 0.01 (micromol) 30 min before zymosan also inhibited the AI. Systemic or local treatment with the NOS inhibitors (L-NAME; AG, 100 mg kg(-1) i.p. or 0.1 micromol joint(-1); 1400W, 1 mg kg(-1) s.c. or 0.01 micromol joint(-1)), 2 h after zymosan did not affect the subsequent AI. Local treatment with the NO donors SNP or SIN-1, 2 h after zymosan did inhibit AI. L-NAME and AG, given i.p. inhibited nitrite but not prostaglandin E(2) (PGE(2)) levels in the joints. L-NAME (100 mg kg(-1)) but not AG (100 mg kg(-1)) increased mean arterial blood pressure. Neither L-NAME, AG nor the NO donor SIN-1 altered articular oedema induced by zymosan. In conclusion, inhibitors of iNOS decrease pain in zymosan arthritis only when given before the zymosan. This was not due to inhibition of articular PGE(2) release or oedema. NO donors also promoted antinociception in zymosan arthritis without affecting oedema.

Citing Articles

The Lectin Isolated from the Alga Hypnea cervicornis Promotes Antinociception in Rats Subjected to Zymosan-Induced Arthritis: Involvement of cGMP Signalization and Cytokine Expression.

de Souza Ferreira Bringel P, Marques G, de Queiroz Martins M, da Silva M, Nobre C, do Nascimento K Inflammation. 2020; 43(4):1446-1454.

PMID: 32212035 DOI: 10.1007/s10753-020-01222-z.

Anti-Inflammatory and Antiarthritic Activities of Aqueous and Ethanolic Extracts of Cogn. (Melastomataceae) in Rats.

Djuichou Nguemnang S, Tsafack E, Mbiantcha M, Gilbert A, Atsamo A, Yousseu Nana W Evid Based Complement Alternat Med. 2019; 2019:3612481.

PMID: 31827550 PMC: 6881768. DOI: 10.1155/2019/3612481.

Synthesis and biological evaluation of new 1,3-thiazolidine-4-one derivatives of nitro-l-arginine methyl ester.

Panzariu A, Apotrosoaei M, Vasincu I, Dragan M, Constantin S, Buron F Chem Cent J. 2016; 10:6.

PMID: 26855668 PMC: 4743259. DOI: 10.1186/s13065-016-0151-6.

Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway.

Staurengo-Ferrari L, Zarpelon A, Longhi-Balbinot D, Marchesi M, Cunha T, Alves-Filho J Pharmacol Rep. 2014; 66(4):691-8.

PMID: 24948073 PMC: 4104808. DOI: 10.1016/j.pharep.2014.04.003.

Tadalafil analgesia in experimental arthritis involves suppression of intra-articular TNF release.

Rocha F, Silva Jr F, Leite A, Leite A, Girao V, Castro R Br J Pharmacol. 2011; 164(2b):828-35.

PMID: 21557731 PMC: 3188897. DOI: 10.1111/j.1476-5381.2011.01469.x.

References

Kamisaki Y, Nakamoto K, Wada K, Itoh T . Nitric oxide regulates substance P release from rat spinal cord synaptosomes. J Neurochem. 1995; 65(5):2050-6. DOI: 10.1046/j.1471-4159.1995.65052050.x. View

Stefanovic-Racic M, Meyers K, Meschter C, Coffey J, Hoffman R, Evans C . Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol. 1995; 22(10):1922-8. View

Kindgen-Milles D, ARNDT J . Nitric oxide as a chemical link in the generation of pain from veins in humans. Pain. 1996; 64(1):139-142. DOI: 10.1016/0304-3959(95)00081-X. View

Song X, Mizel D, Wahl S . Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J Immunol. 2001; 166(4):2734-40. DOI: 10.4049/jimmunol.166.4.2734. View

Berrazueta J, Losada A, Poveda J, Ochoteco A, Riestra A, Salas E . Successful treatment of shoulder pain syndrome due to supraspinatus tendinitis with transdermal nitroglycerin. A double blind study. Pain. 1996; 66(1):63-67. DOI: 10.1016/0304-3959(96)03021-7. View

Sendo T, Kataoka Y, Takeda Y, Furuta W, Oishi R . Nitric oxide protects against contrast media-increased pulmonary vascular permeability in rats. Invest Radiol. 2000; 35(8):472-8. DOI: 10.1097/00004424-200008000-00003. View

Salvemini D, Misko T, Masferrer J, Seibert K, Currie M, NEEDLEMAN P . Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A. 1993; 90(15):7240-4. PMC: 47112. DOI: 10.1073/pnas.90.15.7240. View

Ridger V, Pettipher E, Bryant C, Brain S . Effect of the inducible nitric oxide synthase inhibitors aminoguanidine and L-N6-(1-iminoethyl)lysine on zymosan-induced plasma extravasation in rat skin. J Immunol. 1997; 159(1):383-90. View

Ferreira S, Duarte I, Lorenzetti B . The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol. 1991; 201(1):121-2. DOI: 10.1016/0014-2999(91)90333-l. View

10.

Tal . A Role for Inflammation in Chronic Pain. Curr Rev Pain. 2000; 3(6):440-446. DOI: 10.1007/s11916-999-0071-4. View

11.

Holthusen H, ARNDT J . Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci Lett. 1994; 165(1-2):71-4. DOI: 10.1016/0304-3940(94)90712-9. View

12.

Laszlo F, Evans S, Whittle B . Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharmacol. 1995; 272(2-3):169-75. DOI: 10.1016/0014-2999(94)00637-m. View

13.

Rocha F, Aragao Jr A, Oliveira R, Pompeu M, Vale M, Ribeiro R . Periarthritis promotes gait disturbance in zymosan-induced arthritis in rats. Inflamm Res. 1999; 48(9):485-90. DOI: 10.1007/s000110050491. View

14.

Salvemini D, Wang Z, Wyatt P, Bourdon D, Marino M, Manning P . Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol. 1996; 118(4):829-38. PMC: 1909531. DOI: 10.1111/j.1476-5381.1996.tb15475.x. View

15.

Durate I, Lorenzetti B, Ferreira S . Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur J Pharmacol. 1990; 186(2-3):289-93. DOI: 10.1016/0014-2999(90)90446-d. View

16.

Cicala C, Ianaro A, Fiorucci S, Calignano A, Bucci M, Gerli R . NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol. 2000; 130(6):1399-405. PMC: 1572207. DOI: 10.1038/sj.bjp.0703449. View

17.

Ialenti A, Moncada S, Di Rosa M . Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol. 1993; 110(2):701-6. PMC: 2175935. DOI: 10.1111/j.1476-5381.1993.tb13868.x. View

18.

Swierkosz T, Mitchell J, Warner T, Botting R, Vane J . Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol. 1995; 114(7):1335-42. PMC: 1510271. DOI: 10.1111/j.1476-5381.1995.tb13353.x. View

19.

Teixeira M, Williams T, Hellewell P . Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br J Pharmacol. 1993; 110(4):1515-21. PMC: 2175893. DOI: 10.1111/j.1476-5381.1993.tb13994.x. View

20.

Salvemini D, Manning P, Zweifel B, Seibert K, Connor J, Currie M . Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest. 1995; 96(1):301-8. PMC: 185201. DOI: 10.1172/JCI118035. View